Viatris recognised as a Top Employer 2024 in the UK for the second consecutive year - Seite 2

The programme has certified and recognised over 2,300 Top Employers in 121 countries/regions across five continents.   

Receiving the Top Employer certification for the second consecutive year in the UK follows previous accolades for Viatris, comprising the inclusion on Forbes' list of World's Best Employers in 2023 and 2022, 3BL's 100 Best Corporate Citizens list, Newsweek's America's Greenest Companies 2024, TIME's World's Best Companies 2023 list and USA Today's inaugural list of America's Climate Leaders 2023, Fortune's Change the World list, Newsweek's America's Most Responsible Companies 2022 list, a Great Place to Work certification in India, Capital Magazine's Best Employers in France list, and HR Asia's Best Companies to Work for in Asia (Taiwan), among others.  

To learn more about Viatris' award-winning culture, please visit its careers site. You can also learn more by reading its  2022 Sustainability Report. Through this publication, Viatris describes its approach to actions and initiatives across multiple focus areas, supporting its efforts to be a model for sustainable access to medicine and to make a difference.

About Viatris   

Viatris Inc. (NASDAQ: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale. In 2022 alone, we supplied high-quality medicines to approximately 1 billion patients around the world. With our exceptionally extensive and diverse portfolio of medicines, a one-of-a-kind global supply chain designed to reach more people when and where they need them, and the scientific expertise to address some of the world's most enduring health challenges, access takes on deep meaning at Viatris. We have the ability to touch all of life's moments, from birth to end of life, acute conditions to chronic diseases. We are headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India. Learn more at viatris.com and investor.viatris.com, and connect with us on Twitter, LinkedIn, Instagram and YouTube.